NCT02124681View on ClinicalTrials.gov

Rediscovering Hydroxychloroquine as a Novel Insulin Sensitizer

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Insulin Resistance
Interventions
DRUG

Hydroxychloroquine

Hydroxychloroquine sulfate 400mg/d PO for 13±1 weeks

OTHER

Placebo

Placebo PO for 13±1 weeks

Trial Locations (1)

15234

UPMC Montefiore Hospital, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT02124681 - Rediscovering Hydroxychloroquine as a Novel Insulin Sensitizer | Biotech Hunter | Biotech Hunter